Brian Lin, PhD

Research portfolio director at the Muscular Dystrophy Association.

Articles by Brian Lin, PhD

Brian Lin, PhD, on Using Genetics, Biomarkers, and Clinical Trial Readiness to Enhance ALS Care

January 13th 2026

The research portfolio director at the Muscular Dystrophy Association discussed how ongoing advances in ALS research may inform therapeutic development approaches.

Brian Lin, PhD

Articles by Brian Lin, PhD

Brian Lin, PhD, on Using Genetics, Biomarkers, and Clinical Trial Readiness to Enhance ALS Care

Latest Updated Articles

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – February 4, 2026

Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again

Guess the Therapy Answer February 4, 2026